{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:20:29Z","timestamp":1787167229112,"version":"build-2736575974"},"reference-count":119,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T00:00:00Z","timestamp":1528675200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","award":["ROL 9849"],"award-info":[{"award-number":["ROL 9849"]}],"id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2018.00170","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T08:36:56Z","timestamp":1528706216000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":53,"title":["Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease"],"prefix":"10.3389","volume":"5","author":[{"given":"Roberta","family":"Bertelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Caridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Canepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. M.","family":"Ghiggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1056\/NEJM196907242810402","article-title":"Progression of \u201clipoid nephrosis\u201d to renal insufficiency","volume":"281","author":"Hayslett","year":"1969","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000183575","article-title":"Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions","volume":"41","author":"Tejani","year":"1985","journal-title":"Nephron"},{"key":"B3","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nrneph.2016.147","article-title":"Minimal change disease and idiopathic FSGS: manifestations of the same disease","volume":"12","author":"Maas","year":"2016","journal-title":"Nat Rev Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nrneph.2014.216","article-title":"Causes and pathogenesis of focal segmental glomerulosclerosis","volume":"11","author":"Fogo","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s10157-008-0117-7","article-title":"Steroid-sensitive nephrotic syndrome in two families","volume":"13","author":"Motoyama","year":"2009","journal-title":"Clin Exp Nephrol."},{"key":"B6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1399-0039.1994.tb02340.x","article-title":"HLA class II associations with idiopathic nephrotic syndrome in children","volume":"43","author":"Konrad","year":"1994","journal-title":"Tissue Antigens"},{"key":"B7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1042\/cs0780391","article-title":"Genes encoding the beta-chains of HLA-DR7 and HLA-DQw2 define major susceptibility determinants for idiopathic nephrotic syndrome","volume":"78","author":"Clark","year":"1990","journal-title":"Clin Sci."},{"key":"B8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ki.1990.179","article-title":"HLA extended haplotypes in steroid-sensitive nephrotic syndrome of childhood","volume":"38","author":"Lagueruela","year":"1990","journal-title":"Kidney Int."},{"key":"B9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000188540","article-title":"Association of DQB1*0302 alloantigens in Japanese pediatric patients with steroid-sensitive nephrotic syndrome","volume":"70","author":"Abe","year":"1995","journal-title":"Nephron"},{"key":"B10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/adc.60.11.1018","article-title":"High incidence of minimal change nephrotic syndrome in Asians","volume":"60","author":"Feehally","year":"1985","journal-title":"Arch Dis Child"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/ng1918","article-title":"Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible","volume":"38","author":"Hinkes","year":"2006","journal-title":"Nat Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1681\/ASN.2014030247","article-title":"HLA-DQA1 and PLCG2 are candidate risk loci for childhood-onset steroid-sensitive nephrotic syndrome","volume":"26","author":"Gbadegesin","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ng.3118","article-title":"Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens","volume":"46","author":"Kiryluk","year":"2014","journal-title":"Nat Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1681\/ASN.2007080842","article-title":"Familial nephropathy and multiple exostoses with exostosin-1 (EXT1) gene mutation","volume":"19","author":"Roberts","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.ajhg.2014.04.010","article-title":"Mutations in EMP2 cause childhood-onset nephrotic syndrome","volume":"94","author":"Gee","year":"2014","journal-title":"Am J Hum Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1172\/JCI79504","article-title":"KANK deficiency leads to podocyte dysfunction and nephrotic syndrome","volume":"125","author":"Gee","year":"2015","journal-title":"J Clin Invest."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1111\/j.1523-1755.2004.00583.x","article-title":"Nephrin gene (NPHS1) in patients with minimal change nephrotic syndrome (MCNS)","volume":"65","author":"Lahdenkari","year":"2004","journal-title":"Kidney Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.2215\/CJN.03770412","article-title":"Onco-nephrology: glomerular diseases with cancer","volume":"7","author":"Cambier","year":"2012","journal-title":"Clin J Am Soc Nephrol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrneph.2010.171","article-title":"Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis","volume":"7","author":"Lien","year":"2011","journal-title":"Nat Rev Nephrol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1053\/j.ajkd.2010.07.009","article-title":"The spectrum of kidney involvement in lymphoma: a case report and review of the literature","volume":"56","author":"Cohen","year":"2010","journal-title":"Am J Kidney Dis."},{"key":"B21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1523-1755.1999.00548.x","article-title":"Paraneoplastic glomerulopathies: new insights into an old entity","volume":"56","author":"Ronco","year":"1999","journal-title":"Kidney Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/MD.0000000000000206","article-title":"Minimal change nephrotic syndrome associated with non-Hodgkin lymphoid disorders: a retrospective study of 18 cases","volume":"93","author":"Kofman","year":"2014","journal-title":"Medicine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/ndt\/gfh615","article-title":"Group d'Etudes des nephropaties associees aux thymomes renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature","volume":"20","author":"Karras","year":"2005","journal-title":"Nephrol Dial Transplant."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/sj.ki.5000341","article-title":"Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature","volume":"69","author":"Audard","year":"2006","journal-title":"Kidney Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1182\/blood-2009-11-251132","article-title":"Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes","volume":"115","author":"Audard","year":"2010","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJM197804132981507","article-title":"Molecular basis of proteinuria of glomerular origin","volume":"298","author":"Brenner","year":"1978","journal-title":"N Engl J Med."},{"key":"B27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/ki.1987.243","article-title":"Characterization of cationic albumin in minimal change nephropathy","volume":"32","author":"Ghiggeri","year":"1987","journal-title":"Kidney Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1517\/14656566.6.9.1539","article-title":"Treatment of focal segmental glomerulosclerosis","volume":"6","author":"Meyrier","year":"2005","journal-title":"Expert Opin Pharmacother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nm.1857","article-title":"The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A","volume":"14","author":"Faul","year":"2008","journal-title":"Nat Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/sj.ki.5001796","article-title":"Recurrent autosomal-dominant focal segmental glomerulosclerosis","volume":"70","author":"Sanna-Cherchi","year":"2006","journal-title":"Kidney Int."},{"key":"B31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ki.1991.232","article-title":"A glomerular permeability factor produced by human T cell hybridomas","volume":"40","author":"Koyama","year":"1991","journal-title":"Kidney Int."},{"key":"B32","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1046\/j.1523-1755.2000.00870.x","article-title":"Dominant T cells in idiopathic nephrotic syndrome of childhood","volume":"57","author":"Frank","year":"2000","journal-title":"Kidney Int."},{"key":"B33","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ki.1991.293","article-title":"T-lymphocyte subsets in nephrotic syndrome","volume":"40","author":"Fiser","year":"1991","journal-title":"Kidney Int."},{"key":"B34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1681\/ASN.V103529","article-title":"Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse","volume":"10","author":"Yap","year":"1999","journal-title":"J Am Soc Nephrol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.clim.2011.02.018","article-title":"Th17\/Treg imbalance in adult patients with minimal change nephrotic syndrome","volume":"139","author":"Liu","year":"2011","journal-title":"Clin Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1053\/ajkd.2002.32769","article-title":"T-lymphocyte populations and cytokines in childhood nephrotic syndrome","volume":"39","author":"Lama","year":"2002","journal-title":"Am J Kidney Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s00467-009-1214-x","article-title":"T regulatory cell function in idiopathic minimal lesion nephrotic syndrome","volume":"24","author":"Araya","year":"2009","journal-title":"Pediatr Nephrol."},{"key":"B38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s004670050592","article-title":"Up-regulation of interleukin-4 and CD23\/FcepsilonRII in minimal change nephrotic syndrome","volume":"13","author":"Cho","year":"1999","journal-title":"Pediatr Nephrol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1111\/j.1523-1755.2005.00664.x","article-title":"Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo\/Mna rats","volume":"68","author":"Le Berre","year":"2005","journal-title":"Kidney Int."},{"key":"B40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1681\/ASN.2007111244","article-title":"Induction of T regulatory cells attenuates idiopathic nephrotic syndrome","volume":"20","author":"Le Berre","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1681\/ASN.2006070710","article-title":"Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats","volume":"18","author":"Lai","year":"2007","journal-title":"J Am Soc Nephrol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1681\/ASN.2011030304","article-title":"Basic and translational concepts of immune-mediated glomerular diseases","volume":"23","author":"Couser","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/cei.12675","article-title":"Regulatory T cells and minimal change nephropathy: in the midst of a complex network","volume":"183","author":"Bertelli","year":"2016","journal-title":"Clin Exp Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1681\/ASN.2011090914","article-title":"CD8+ regulatory T cells induced by T cell vaccination protect against autoimmune nephritis","volume":"23","author":"Wang","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1681\/ASN.2011111130","article-title":"IL-2\/IL-2Ab complexes induce regulatory T cell expansion and protect against proteinuric CKD","volume":"23","author":"Polhill","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e111285","DOI":"10.1371\/journal.pone.0111285","article-title":"LPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activity","volume":"9","author":"Bertelli","year":"2014","journal-title":"PLoS ONE"},{"key":"B48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1365-2249.2010.04160.x","article-title":"Failure of regulation results in an amplified oxidation burst by neutrophils in children with primary nephrotic syndrome","volume":"161","author":"Bertelli","year":"2010","journal-title":"Clin Exp Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2249.2011.04441.x","article-title":"Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome","volume":"166","author":"Bertelli","year":"2011","journal-title":"Clin Exp Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N Engl J Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T cells in graft-versus-host disease","volume":"365","author":"Koreth","year":"2011","journal-title":"N Engl J Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0138343","DOI":"10.1371\/journal.pone.0138343","article-title":"A pilot study of IL2 in drug-resistant idiopathic nephrotic syndrome","volume":"10","author":"Bonanni","year":"2015","journal-title":"PLoS ONE"},{"key":"B53","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2215\/CJN.08500815","article-title":"Anti-CD20 antibodies for idiopathic nephrotic syndrome in children","volume":"11","author":"Ravani","year":"2016","journal-title":"Clin J Am Soc Nephrol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1681\/ASN.2014080799","article-title":"Rituximab in children with steroid-dependent nephrotic syndrome: a multicenter, open-label, noninferiority, randomized controlled trial","volume":"26","author":"Ravani","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci Transl Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1681\/ASN.2013111213","article-title":"Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease","volume":"26","author":"Yoo","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/cei.12771","article-title":"Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjogren's syndrome: a pilot study","volume":"184","author":"Alunno","year":"2016","journal-title":"Clin Exp Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/art.30314","article-title":"The anti-CD20 antibody rituximab reduces the Th17 cell response","volume":"63","author":"van de Veerdonk","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B59","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3181\/00379727-89-21833","article-title":"Experimental nephrotic syndrome induced in rats by aminonucleoside; renal lesions and body electrolyte composition","volume":"89","author":"Frenk","year":"1955","journal-title":"Proc Soc Exp Biol Med."},{"key":"B60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ki.1991.176","article-title":"Puromycin aminonucleoside metabolism by glomeruli and glomerular epithelial cells in vitro","volume":"40","author":"Ghiggeri","year":"1991","journal-title":"Kidney Int."},{"key":"B61","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1042\/cs0780283","article-title":"Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis","volume":"78","author":"Ginevri","year":"1990","journal-title":"Clin Sci."},{"key":"B62","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0006-2952(92)90413-D","article-title":"Evaluation of adriamycin-induced lipid peroxidation","volume":"44","author":"Fukuda","year":"1992","journal-title":"Biochem Pharmacol."},{"key":"B63","first-page":"40","article-title":"Puromycin aminonucleoside and adriamycin disturb cytoskeletal and extracellular matrix protein organization, but not protein synthesis of cultured glomerular epithelial cells","volume":"2","author":"Coers","year":"1994","journal-title":"Exp Nephrol."},{"key":"B64","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1006\/bbrc.1993.2135","article-title":"A deletion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity","volume":"195","author":"Adachi","year":"1993","journal-title":"Biochem Biophys Res Commun."},{"key":"B65","first-page":"16","article-title":"Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events","volume":"46","author":"Bertani","year":"1982","journal-title":"Lab Invest."},{"key":"B66","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1172\/JCI43721","article-title":"Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice","volume":"120","author":"Papeta","year":"2010","journal-title":"J Clin Invest."},{"key":"B67","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0378-4274(98)00024-1","article-title":"The role of reactive oxygen species in adriamycin and menadione-induced glomerular toxicity","volume":"94","author":"Morgan","year":"1998","journal-title":"Toxicol Lett."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI20402","article-title":"Induction of B7-1 in podocytes is associated with nephrotic syndrome","volume":"113","author":"Reiser","year":"2004","journal-title":"J Clin Invest."},{"key":"B69","first-page":"1066","article-title":"A single dominant susceptible gene determines spontaneous development of thymoma in BUF\/Mna rat","volume":"77","author":"Matsuyama","year":"1986","journal-title":"Jpn J Cancer Res."},{"key":"B70","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1655::AID-MUS5>3.0.CO;2-F","article-title":"Spontaneous thymoma rat as a model for myasthenic weakness caused by anti-ryanodine receptor antibodies","volume":"21","author":"Iwasa","year":"1998","journal-title":"Muscle Nerve"},{"key":"B71","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000185890","article-title":"Genetic regulation of the development of glomerular sclerotic lesions in the BUF\/Mna rat","volume":"54","author":"Matsuyama","year":"1990","journal-title":"Nephron"},{"key":"B72","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s003359900888","article-title":"A genetic locus susceptible to the overt proteinuria in BUF\/Mna rat","volume":"9","author":"Murayama","year":"1998","journal-title":"Mamm Genome"},{"key":"B73","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1172\/JCI12858","article-title":"Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo\/Mna rats","volume":"109","author":"Le Berre","year":"2002","journal-title":"J Clin Invest."},{"key":"B74","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1681\/ASN.2006090965","article-title":"Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin","volume":"18","author":"Musante","year":"2007","journal-title":"J Am Soc Nephrol."},{"key":"B75","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1006\/bbrc.1995.2820","article-title":"Procathepsin L degrades extracellular matrix proteins in the presence of glycosaminoglycans in vitro","volume":"217","author":"Ishidoh","year":"1995","journal-title":"Biochem Biophys Res Commun."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1172\/JCI32022","article-title":"Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease","volume":"117","author":"Sever","year":"2007","journal-title":"J Clin Invest."},{"key":"B77","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000447692","article-title":"A critical evaluation of anti-IL-13 and anti-IL-4 strategies in severe asthma","volume":"170","author":"Bagnasco","year":"2016","journal-title":"Int Arch Allergy Immunol."},{"key":"B78","first-page":"925","article-title":"IL-4 and IL-13 inhibition in atopic dermatitis","volume":"15","author":"Matsunaga","year":"2016","journal-title":"J Drugs Dermatol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S0140-6736(15)00157-9","article-title":"Targeting the interleukin pathway in the treatment of asthma","volume":"386","author":"Chung","year":"2015","journal-title":"Lancet"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e2556","DOI":"10.1097\/MD.0000000000002556","article-title":"The efficacy and safety of antiinterleukin 13, a monoclonal antibody, in adult patients with asthma: a systematic review and meta-analysis","volume":"95","author":"Luo","year":"2016","journal-title":"Medicine"},{"key":"B81","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/ndt\/gfr271","article-title":"Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-kappaB-dependent pathway","volume":"27","author":"Shimada","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"B82","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/70905","article-title":"T-cell stimulation: an abundance of B7s","volume":"5","author":"Abbas","year":"1999","journal-title":"Nat Med."},{"key":"B83","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0955-0674(99)80027-1","article-title":"Costimulatory regulation of T cell function","volume":"11","author":"Chambers","year":"1999","journal-title":"Curr Opin Cell Biol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1681\/ASN.2007080836","article-title":"Urinary CD80 excretion increases in idiopathic minimal-change disease","volume":"20","author":"Garin","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/ki.2010.143","article-title":"Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis","volume":"78","author":"Garin","year":"2010","journal-title":"Kidney Int."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00467-017-3613-8","article-title":"Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome","volume":"32","author":"Mishra","year":"2017","journal-title":"Pediatr Nephrol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1681\/ASN.2013050518","article-title":"Role of podocyte B7-1 in diabetic nephropathy","volume":"25","author":"Fiorina","year":"2014","journal-title":"J Am Soc Nephrol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","article-title":"Abatacept in B7-1-positive proteinuric kidney disease","volume":"369","author":"Yu","year":"2013","journal-title":"N Engl J Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1681\/ASN.2015091002","article-title":"B7-1 blockade does not improve post-transplant nephrotic syndrome caused by recurrent FSGS","volume":"27","author":"Delville","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev.immunol.22.012703.104533","article-title":"CD40\/CD154 interactions at the interface of tolerance and immunity","volume":"22","author":"Quezada","year":"2004","journal-title":"Annu Rev Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.imbio.2011.03.010","article-title":"CD40 ligand: a neo-inflammatory molecule in vascular diseases","volume":"217","author":"Hassan","year":"2012","journal-title":"Immunobiology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1046\/j.1523-1755.2003.00223.x","article-title":"Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease","volume":"64","author":"Kairaitis","year":"2003","journal-title":"Kidney Int."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e0188045","DOI":"10.1371\/journal.pone.0188045","article-title":"Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS","volume":"12","author":"Doublier","year":"2017","journal-title":"PLoS ONE"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1097\/01.ASN.0000091381.60059.FB","article-title":"Intrinsic renal cell expression of CD40 directs Th1 effectors inducing experimental crescentic glomerulonephritis","volume":"14","author":"Ruth","year":"2003","journal-title":"J Am Soc Nephrol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/j.1523-1755.2004.00907.x","article-title":"Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis","volume":"66","author":"Reynolds","year":"2004","journal-title":"Kidney Int."},{"key":"B96","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/ndt\/gfp569","article-title":"The CD40-CD154 co-stimulation pathway mediates innate immune injury in adriamycin nephrosis","volume":"25","author":"Lee","year":"2010","journal-title":"Nephrol Dial Transplant."},{"key":"B97","doi-asserted-by":"publisher","first-page":"256ra136","DOI":"10.1126\/scitranslmed.3008538","article-title":"A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation","volume":"6","author":"Delville","year":"2014","journal-title":"Sci Transl Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00281-013-0415-3","article-title":"Immunopathogenesis of idiopathic nephrotic syndrome with relapse","volume":"36","author":"Sahali","year":"2014","journal-title":"Semin Immunopathol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"ra39","DOI":"10.1126\/scisignal.2000678","article-title":"Desvaux c-mip impairs podocyte proximal signaling and induces heavy proteinuria","volume":"3","author":"Zhang","year":"2010","journal-title":"Sci Signal."},{"key":"B100","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrclinonc.2009.130","article-title":"An overview of small-molecule inhibitors of VEGFR signaling","volume":"6","author":"Ivy","year":"2009","journal-title":"Nat Rev Clin Oncol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ejca.2009.11.00","article-title":"VEGF signalling inhibition-induced proteinuria: mechanisms, significance and management","volume":"46","author":"Izzedine","year":"2010","journal-title":"Eur J Cancer"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.neuroscience.2009.05.019","article-title":"Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice","volume":"162","author":"Echeverria","year":"2009","journal-title":"Neuroscience"},{"key":"B103","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.molimm.2008.09.034","article-title":"C-mip interacts physically with RelA and inhibits nuclear factor kappa B activity","volume":"46","author":"Kamal","year":"2009","journal-title":"Mol Immunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/ki.2012.426","article-title":"Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy","volume":"83","author":"Sendeyo","year":"2013","journal-title":"Kidney Int."},{"key":"B105","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.molmed.2007.06.006","article-title":"Nephrin\u2013a unique structural and signaling protein of the kidney filter","volume":"13","author":"Patrakka","year":"2007","journal-title":"Trends Mol Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0955-0674(00)00140-X","article-title":"Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth","volume":"12","author":"Ossowski","year":"2000","journal-title":"Curr Opin Cell Biol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor","volume":"14","author":"Wei","year":"2008","journal-title":"Nat Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1056\/NEJMoa1506362","article-title":"Soluble urokinase receptor and chronic kidney disease","volume":"373","author":"Hayek","year":"2015","journal-title":"N Engl J Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nm.4362","article-title":"A tripartite complex of suPAR, APOL1 risk variants and alphavbeta3 integrin on podocytes mediates chronic kidney disease","volume":"23","author":"Hayek","year":"2017","journal-title":"Nat Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1053\/j.ajkd.2011.07.024","article-title":"New insights into human minimal change disease: lessons from animal models","volume":"59","author":"Chugh","year":"2012","journal-title":"Am J Kidney Dis."},{"key":"B113","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nm.2261","article-title":"Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome","volume":"17","author":"Clement","year":"2011","journal-title":"Nat Med."},{"key":"B114","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/bbrc.1995.1173","article-title":"The type II hemopexin interleukin-6 response element predominates the transcriptional regulation of the hemopexin acute phase responsiveness","volume":"207","author":"Immenschuh","year":"1995","journal-title":"Biochem Biophys Res Commun."},{"key":"B115","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/clinchem\/41.12.1819","article-title":"Lipid peroxidation and antioxidants as biomarkers of tissue damage","volume":"41","author":"Gutteridge","year":"1995","journal-title":"Clin Chem."},{"key":"B116","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1681\/ASN.2007080940","article-title":"Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes","volume":"19","author":"Lennon","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1007\/s00467-005-1936-3","article-title":"Altered activity of plasma hemopexin in patients with minimal change disease in relapse","volume":"20","author":"Bakker","year":"2005","journal-title":"Pediatr Nephrol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.2215\/CJN.09421010","article-title":"Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial","volume":"6","author":"Ravani","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ki.2013.211","article-title":"Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome","volume":"84","author":"Ravani","year":"2013","journal-title":"Kidney Int."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00170\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T08:27:06Z","timestamp":1661416026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00170\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,11]]},"references-count":119,"alternative-id":["10.3389\/fmed.2018.00170"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2018.00170","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,11]]},"article-number":"170"}}